PRESOL | 65 | Purchase of the following Grifols Quest reagents for the Microbiology Department at Brooke Army Medical Center, Fort Sam Houston, TX: Seraquest Rubella, Wampole TOXO, Wampole HSV, Seraquest VZV, Seraquest Measles, and Seraquest Mumps.

FBO DAILY ISSUE OF SEPTEMBER 02, 2007 FBO #2106
SOLICITATION NOTICE

65 -- Purchase of the following Grifols Quest reagents for the Microbiology Department at Brooke Army Medical Center, Fort Sam Houston, TX: Seraquest Rubella, Wampole TOXO, Wampole HSV, Seraquest VZV, Seraquest Measles, and Seraquest Mumps.

Notice Date: 8/31/2007
Notice Type: Solicitation Notice
NAICS: 424210 — Drugs and Druggists' Sundries Merchant Wholesalers
Contracting Office: Great Plains Regional Contracting Ofc, ATTN: MCAA GP L31 9V, 3851 Roger Brooke Drive, Fort Sam Houston, TX 78234-6200
ZIP Code: 78234-6200
Solicitation Number: W81NWY71768442
Response Due: 9/7/2007
Archive Date: 11/6/2007
Small Business Set-Aside: N/A
Description: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. Solicitation W81NWY71768442 is issued as a request for quotation (RFQ). This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-18. This acquisition is solicited on an unrestricted basis for NAICS 424210, size standard 100 employees. Federal Acquisition Regulation (FAR) Clause 52.211-6 Brand Name or Equal applies to Grifols-Quest Inc. products listed below. Vendors shall provide quotes for the following products ( Items 0001 to 0021 ): 0001 Wampole Toxo,5 Kits,IGG-96,Cat#425100CE; 0002 Wampole Toxo,5 Kits, IGM-96,Cat#425150CE; 0003 Wampole HSV,4 Kits,IGG-96,Cat#425400CE; 0004 Wampole CMV,20 Kits,IGG-96,Cat#425200CE; 0005 Wampole CMV, 20 Kits,IGM-96,Cat#425250CE; 0006 Wampole H.Pylori,30 Kits,IGG-96,Cat#425250CE; 0007 Wampole EBV VCA (P-18),15 Kits,IGG Cat#424700CE; 0008 Wampole EBV VCA IGM 15 Kits,Cat#425760CE; 0009 Wampole EBV Lyme,15 Kits,IGG/IGM-96 Cat#446580CE; 0010 Wampole Mycoplasma, 6 Kits;IGG-96 Cat#444800 CE; 0011 Wampole EBNA 15 Kits,IGG-96 Cat#425800CE; 0012 Wampole Rubella, 20 Kits,IGG Cat#425031CD; 0013 Wampole VZ, 15 Kits,IGG-180 Cat#425601CE; 0014 Wampole Chlamydia, 5 Kits,IGG Cat#446200; 0015 Wampole Legionella, 3 Kits, IFA Sys Cat#150016; 0016 Wampo le FTA-ABS, 20 Kits, Cat#7001; 0017 Wampole ADB, 70 Kits, Cat#44D2; 0018 Seraquest Rubella, 4 Kits, IGG-96 Cat#01-100; 0019 Seraquest VZV, 4 Kits, IGG-96 Cat#01-180; 0020 Seraquest Measles 4 Kits, IGG-96, Cat#01-190; 0021 Seraquest Mumps,4 Kits, IGG-96 Cat # 01-200. SALIENT CHARACTERISTICS: OR EQUAL PRODUCTS SHALL BE COMPATIBLE WITH GRIFOLS-QUEST EQUIPMENT TRITURUS EIA ANALYZER CAT# 219500 WITH PC, MONITOR, PRINTER, UPS AND SOFTWARE P/N 444800CE Performance Period: 1 October 2007 to 30 September 2008 to Brooke Army Medical Center, Medical Supply Officer, Warehouse Receiving Dock Bldg 3600, 3851 Roger Brooke Drive, Fort Sam Houston TX 78234-6200. FOB: Destination. Vendors shall comply with FAR 52.211-6 if submitting other than the brand name products. FAR clause 52.211-6 (and other provisions and clauses throughout this solicitation) can be viewed at Internet address: http://farsite.hill.af.mil/vffar1.htm. Defense Federal Acquisition Regulations Supplement (DFARS) provisions and clauses can be viewed at Internet address: http://www.acq.osd.mil/dpap/dars/dfars/. Federal Acquisition Regulation (FAR) provision 52.212-1 [Instructions to Offerors Commercial] applies to this acquisition to include the following addenda: All Offerors are cautioned that if selected for award, they must be registered with the Central C ontractor Registration (CCR) program. The CCR can be accessed at Internet address: www.ccr.gov/. Confirmation of CCR registration will be validated prior to awarding a contract. Evaluation of Quotes: The Government will award a contract resulting from this solicitation to the responsible vendor whose quote, conforming to this solicitation, is Lowest Priced, Technically Acceptable (LPTA). Award will be on an all or none basis. The following factors will be used to evaluate quotes: 1. Technical Acceptability: In order to be considered technically acceptable, vendors must demonstrate that all items proposed [if other than Brand Name] meet or exceed the salient characteristics listed above. 2. Price. All quotes will be evaluated on Technical Acceptability. The award decision will be based on the Lowest Priced, Technically Acceptable quote. Vendors shall include a completed copy of FAR provision 52.212-3 [Offeror Representations and Certifications-Commercial Items] with their quote. FAR clause 52.212-4 [Contract Terms and C onditions Commercial Items] applies to this acquisition. FAR clause 52.212-5 [Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items] and the following sub FAR clauses apply to this acquisition: 52.203-6 [Re strictions on Subcontractor Sales to the Government, Alternate I]; 52.219-8 [Utilization of Small Business Concerns]; 52.219-23 [Notice of Price Evaluation Adjustment for Small Disadvantaged Business Concerns]; 52.222-3 [Convict Labor]; 52.222-19 [Child L abor Cooperation with Authorities and Remedies]; 52.222-21 [Prohibition of Segregated Facilities]; 52.222-26 [Equal Opportunity]; 52.222-35 [Equal Opportunity for Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans]; 5 2.222-36 [Affirmative Action for Workers with Disabilities]; 52.222-37 [Employment Reports on Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans]; 52.222-39 [Notification of Employee Rights Concerning Payment of Union Due s or Fees]; 52.225-13 [Restrictions on Certain Foreign Purchases]; 52.232-33 [Payment by Electronic Funds Transfer-Central Contractor Registration]. Defense Federal Acquisition Regulation Supplement (DFARS) clause 252.212-7001 [Contract Terms and Conditio ns Required to Implement Statutes or Executive Orders Applicable to Defense Acquisitions of Commercial Items] with the following sub FAR and DFARS clauses apply to this acquisition: 52.203-3 [Gratuities]; 252.225-7001 [Buy American Act and Balance of Paym ents Program]; 252.225-7012 [Preference for Certain Domestic Commodities]; 252.225-7021 [Trade Agreements]; 252.232-7003 [Electronic Submission of Payment Requests]; 252.243-7002 [Requests for Equitable Adjustment]; 252.247-7023 [Transportation of Supplies by Sea]. DFARS clause 252.211-7003 [Item Identification and Evaluation] applies. The closing date and time of this solicitation is 07 September 2007, 04:00 p.m. CST. Quotes shall be submitted on company letterhead and signed by a company representative by the closing date and time. Quotes may be submitted via mail, fax, or e-mail. ( mail: Great Plains Regional Contracting Office, Attn: Virginia Gonzales, 3851 Roger Brooke Drive L31-9V, Fort Sam Houston TX 78234-6200; fax: (210) 916-1750, Attn: Virginia Gonzales; e-mail: virginia.gonzales@amedd.army.mil). Paper copies of this solicita tion will not be issued and telephone, fax, or email requests for the solicitation will not be accepted. Point of contact: Virginia Gonzales, telephone: (210) 916-2873; email: Virginia.Gonzales@amedd.army.mil
Place of Performance: Address: Great Plains Regional Contracting Ofc ATTN: MCAA GP L31 9V, 3851 Roger Brooke Drive Fort Sam Houston TX; Zip Code: 78234-6200; Country: US
Record: SN01392515-W 20070902/070831222225 (fbodaily.com)
Source: FedBizOpps Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's FBO Daily Index Page |

Loren Data's SAM Daily™

65 -- Purchase of the following Grifols Quest reagents for the Microbiology Department at Brooke Army Medical Center, Fort Sam Houston, TX: Seraquest Rubella, Wampole TOXO, Wampole HSV, Seraquest VZV, Seraquest Measles, and Seraquest Mumps.